Yoshikawa J, Yanagihara K, Asaka T, Kato H, Okumachi F, Yoshida K, Syomura T
J Cardiogr Suppl. 1984(3):93-7.
Twenty-seven patients in cardiogenic shock or medically refractory left ventricular failure due to acute myocardial infarction were treated with intraaortic balloon counterpulsation. Twenty-one of them were treated with counterpulsation alone; the remaining six underwent surgery. Thirteen patients were benefited by counterpulsation alone. Three of the patients treated with counterpulsation and surgery survived and were discharged from the hospital. Thus, 16 of the 27 patients (59%) survived. Four patients in medically refractory left ventricular failure or shock due to acute myocarditis were treated with counterpulsation. All patients were weaned easily from circulatory assist and were discharged from the hospital. This study shows that intraaortic balloon counterpulsation is a very useful adjunct to currently existing medical measures for the treatment of cardiogenic shock or for medically refractory left ventricular failure in both myocardial infarction and myocarditis.
27例因急性心肌梗死导致心源性休克或药物治疗无效的左心室衰竭患者接受了主动脉内球囊反搏治疗。其中21例仅接受了反搏治疗;其余6例接受了手术。仅反搏治疗使13例患者受益。接受反搏和手术治疗的患者中有3例存活并出院。因此,27例患者中有16例(59%)存活。4例因急性心肌炎导致药物治疗无效的左心室衰竭或休克患者接受了反搏治疗。所有患者均顺利撤掉循环辅助装置并出院。本研究表明,主动脉内球囊反搏是目前现有治疗措施中治疗心肌梗死和心肌炎所致心源性休克或药物治疗无效的左心室衰竭的非常有用的辅助手段。